Conference Proceedings

Durable efficacy of risankizumab compared with ustekinumab across subgroups of patients with moderate-to-severe plaque psoriasis: Integrated analysis of two phase 3 trials

Peter Foley, Bruce Strober, Wendell C Valdecantos, Huzefa Photowala, Tianyu Zhan, Alan Menter

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | MOSBY-ELSEVIER | Published : 2019